Thread by @AlessandroLoio2

"Não existem evidências"...
Çerto.

pubmed.ncbi.nlm.nih.gov/33633920/

"Proxalutamide was also found to reduce the mortality risk by 92 percent".

europeanpharmaceuticalreview.com/news/147167/pr…

"The findings of the present meta-analysis suggest a definite signal of benefit of mortality with the addition of colchicine in patients with COVID-19".

ncbi.nlm.nih.gov/pmc/articles/P…

"Most of the articles reviewed showed that blood vitamin D status can determine the risk of being infected with COVID-19, seriousness of COVID-19, and mortality from COVID-19".

pubmed.ncbi.nlm.nih.gov/33447107/

"Reduced vitamin D values resulted in a higher infection risk, mortality and severity COVID-19 infection. Supplementation may be considered as preventive and therapeutic measure".

pubmed.ncbi.nlm.nih.gov/33775818/

"Patients with mild-to-moderate COVID-19 infection treated with ivermectin plus doxycycline recovered earlier, were less likely to progress to more serious disease, and were more likely to be COVID-19 negative by RT-PCR on day 14".

pubmed.ncbi.nlm.nih.gov/33983065/

"Early treatment with DOXY for high-risk patients with moderate to severe COVID-19 infections in non-hospital settings, such as LTCFs, is associated with early clinical recovery, decreased hospitalization, and decreased mortality".

pubmed.ncbi.nlm.nih.gov/32802622/

"Early nitazoxanide therapy was safe and reduced viral load significantly".

pubmed.ncbi.nlm.nih.gov/33361100/

"Nitazoxanide seems to be useful against SARS-CoV-2, not only in an early intervention but also in critical condition as well as in pregnancy without undesired effects for the babies".

pubmed.ncbi.nlm.nih.gov/33031085/

"Early administration of inhaled budesonide reduced the likelihood of needing urgent medical care and reduced time to recovery after early COVID-19".

pubmed.ncbi.nlm.nih.gov/33844996/